Sign in

CIK 0000885590 · Large accelerated filer

Bausch Health Companies Inc.

Sign in to watch
Ticker
BHC
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NJ
Entity type
operating
Phone
514-744-6792
Business address
2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
Former names
Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
  1. 4 Grant or award Director acquired 3,673 shares (grant or award)
  2. 4 Grant or award Director acquired 1,065 shares (grant or award)
  3. 4 Planned sale EVP, General Counsel sold 13,370 shares at $7.31 ($97,735)
  4. 4 Open-market sale Director sold 15,912 shares at $7.66 ($121,886)
  5. 4 Open-market buy Director bought 34,721,118 shares at $9.00 ($312,490,062)
  6. 3 Insider Initial Statement of Ownership
  7. 4 Open-market buy Director bought 3,243,049 shares at an average $6.56 ($21,267,731)
  8. 4 Grant or award Director acquired 30,149 shares (grant or award)
  9. 3 Insider Initial Statement of Ownership
  10. 4 Grant or award Director acquired 30,149 shares (grant or award)
  11. 3 Insider Initial Statement of Ownership
  12. 4 Grant or award EVP, US Pharma acquired 30,847 shares (grant or award)
  13. 4 Shares withheld for taxes EVP, US Pharma gave up 22,736 shares (to pay taxes)
  14. 4 Grant or award SVP, Controller & CAO acquired 27,371 shares (grant or award)
  15. 3 Insider Initial Statement of Ownership
  16. 4 Grant or award Director acquired 9,384 shares (grant or award)
  17. 4 Grant or award Director acquired 4,034 shares (grant or award)
  18. 4 Grant or award Director acquired 1,032 shares (grant or award)
  19. 4 Open-market buy Director bought 3,564,059 shares at $5.94 ($21,170,510)
  20. 4 Open-market buy Director bought 2,788,608 shares at an average $5.27 ($14,700,257)

Page 3 of 61 · 1,214 filings